Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic Cellular Toxicity from Inhibition of Poly(ADP-ribose) Glycohydrolase (PARG) and Ubiquitin-Specific Protease 1 (USP1). | Toxics | 2026 | 41745836 | PubTator, text mining | PubMed |
| Novel Biallelic LIG3 Mutations Causing Lethal Phenotype With Immunodeficiency. | Am J Med Genet A | 2026 | 41741356 | PubTator, text mining | PubMed |
| α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer. | Cell Death Dis | 2026 | 41723136 | PubTator, text mining | PubMed |
| Genetic polymorphisms in DNA repair gene XRCC1 and the risk of diabetic polyneuropathy. | Sci Rep | 2026 | 41634070 | PubTator, text mining | PubMed |
| Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization. | J Clin Invest | 2026 | 41632544 | PubTator, text mining | PubMed |
| PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma. | Cancer Cell Int | 2026 | 41508015 | PubTator, text mining | PubMed |
| Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis. | NAR Cancer | 2025 | 41480640 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Preventable Causes of Oral Cancer and Precancer Through Polymorphism in DNA Base Excision Repair Genes in Patients with Tobacco Products Habits. | J Maxillofac Oral Surg | 2025 | 41306206 | PubTator, text mining | PubMed |
| JMJD1B-mediated FEN1 demethylation allows timely switching of Okazaki fragment maturation core enzymes to avoid mutagenic flap ligation by PARP1-LIG3. | bioRxiv | 2025 | 41280084 | PubTator, text mining | PubMed |
| The zinc finger of DNA ligase 3α binds to nucleosomes via an arginine anchor. | Nat Commun | 2025 | 41271738 | PubTator, text mining | PubMed |
| Ligase 3 prevents oxidative strand break-induced mitochondrial DNA loss but is not essential for replicative circularization. | Nucleic Acids Res | 2025 | 41099692 | PubTator, text mining | PubMed |
| Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression. | Clin Transl Med | 2025 | 40984821 | PubTator, text mining | PubMed |
| Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III. | J Cell Mol Med | 2025 | 40916080 | PubTator, text mining | PubMed |
| Tumor irradiation induced immunogenic response: the impact of DNA damage induction and misrepair. | Radiat Oncol | 2025 | 40841665 | PubTator, text mining | PubMed |
| Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1-Lig3-PARylation complex. | Mol Cell | 2025 | 40769147 | PubTator, text mining | PubMed |
| Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. | ESMO Open | 2025 | 40768895 | PubTator, text mining | PubMed |
| Mechanistic Insights into Ligand-Mediated Modulation of 14-3-3η/Parkin Interaction through Molecular Dynamics and Enhanced Sampling Simulations. | J Phys Chem B | 2025 | 40622900 | PubTator, text mining | PubMed |
| Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids. | Exp Mol Pathol | 2025 | 40580893 | PubTator, text mining | PubMed |
| Mechanism of cytarabine-induced neurotoxicity. | Nature | 2025 | 40562930 | PubTator, text mining | PubMed |
| Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia. | PLoS One | 2025 | 40493574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=2